Understanding an exotic disease: Initiation of sex and infection by the sugarcane smut Ustilago scitaminea. Australian sugar exports generate almost $2 billion in annual sales, making the sugar industry a critical facet of the Australian economy. In 2006, Australia's primary sugar producing region came under threat when an outbreak of sugarcane smut caused by the fungus Ustilago scitaminea first appeared in Queensland. Management of this potentially devastating disease has focused on breeding pr ....Understanding an exotic disease: Initiation of sex and infection by the sugarcane smut Ustilago scitaminea. Australian sugar exports generate almost $2 billion in annual sales, making the sugar industry a critical facet of the Australian economy. In 2006, Australia's primary sugar producing region came under threat when an outbreak of sugarcane smut caused by the fungus Ustilago scitaminea first appeared in Queensland. Management of this potentially devastating disease has focused on breeding programmes aimed at developing resistant sugarcane cultivars, a complex process hampered by a lack of information about the mechanisms of smut resistance. Our research will provide key insight into the mechanisms by which U. scitaminea infects sugarcane, directing future breeding efforts and protecting this valuable industry against further outbreaks.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE140101493
Funder
Australian Research Council
Funding Amount
$368,720.00
Summary
A glycomics approach towards the discovery of novel markers of virus transmission by mosquitoes. The incidence of human and animal diseases caused by mosquito-borne pathogens has increased at an alarming rate globally. This project utilises state-of-the-art glyco-virological approaches and an arbovirus model system to identify new markers associated with virus transmission by mosquitoes. Markers associated with transmission will be identified by establishing global glycan and lectin profiles of ....A glycomics approach towards the discovery of novel markers of virus transmission by mosquitoes. The incidence of human and animal diseases caused by mosquito-borne pathogens has increased at an alarming rate globally. This project utilises state-of-the-art glyco-virological approaches and an arbovirus model system to identify new markers associated with virus transmission by mosquitoes. Markers associated with transmission will be identified by establishing global glycan and lectin profiles of the cells derived from a major mosquito species. This will fill a significant gap in our knowledge of basic transmission mechanisms in mosquitoes. The research strategy is a world-first and the institute is an international leader in this area. Read moreRead less
In-Vitro Production of Baculovirus Biopesticides - A Systems Biology Approach. This project has the potential to develop an in-vitro production process that can produce large quantities of Baculoviruses at costs comparable to selective chemicals. This could transform agriculture allowing farmers to choose an insect control option that is both safe and efficacious to use as well as economically and environmentally superior to chemicals, and less controversial than transgenic plants. This outcome ....In-Vitro Production of Baculovirus Biopesticides - A Systems Biology Approach. This project has the potential to develop an in-vitro production process that can produce large quantities of Baculoviruses at costs comparable to selective chemicals. This could transform agriculture allowing farmers to choose an insect control option that is both safe and efficacious to use as well as economically and environmentally superior to chemicals, and less controversial than transgenic plants. This outcome would enhance Australia's reputation in the animal cell technology field (related technology is used to produce protein pharmaceutical products), and will earn significant export dollars through licensing out of the technology or through large scale manufacturing and export of the product itself. Read moreRead less
Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala ....Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala care centres, wildlife hospitals and government departments.Read moreRead less
Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in ....Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Read moreRead less